Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 226 entries
View as:

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

Phase: N/A Priority: Normal
NCT ID: NCT05215106 Org: User:
Start: 12/06/21 End: 06/30/26 Due: 06/30/27

Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02997332 Org: User:
Start: 03/30/17 End: 12/31/19 Due: 12/31/20

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04842162 Org: User:
Start: 12/15/20 End: 11/30/26 Due: 11/30/27

Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence

Phase: N/A Priority: Normal
NCT ID: NCT05071001 Org: User:
Start: 03/19/21 End: 04/07/25 Due: 04/07/26

Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling

Phase: N/A Priority: Normal
NCT ID: NCT02613962 Org: User:
Start: 01/13/16 End: 01/31/22 Due: 01/31/23

Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01268202 Org: User:
Start: 12/17/10 End: 04/18/19 Due: 04/18/20

Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02390934 Org: User:
Start: 10/01/14 End: 04/02/19 Due: 04/02/20

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Phase: N/A Priority: Normal
NCT ID: NCT06907095 Org: User:
Start: 06/30/25 End: 06/30/30 Due: 06/30/31

Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01403324 Org: User:
Start: 09/30/11 End: 06/30/16 Due: 06/30/17

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00935675 Org: User:
Start: - End: - Due: -

Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04775121 Org: User:
Start: 05/13/19 End: 11/04/23 Due: 11/04/24

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00126230 Org: User:
Start: 01/31/04 End: - Due: -

Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04276376 Org: User:
Start: 04/12/19 End: 04/30/25 Due: 04/30/26

USE OF 18FDG PET-CT TO PREDICT THE RESPONSE OF MANDIBULAR OSTEORADIONECROSIS TO THE PENTOCLO PROTOCOL WITH DOCUMENTED ANTIBIOTHERAPY

Phase: N/A Priority: Normal
NCT ID: NCT04826445 Org: User:
Start: 06/11/19 End: 06/30/24 Due: 06/30/25

Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +

Phase: N/A Priority: Normal
NCT ID: NCT02902874 Org: User:
Start: 04/21/10 End: 12/31/20 Due: 12/31/21

Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04304924 Org: User:
Start: 06/17/20 End: 03/31/23 Due: 03/31/24

Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00127049 Org: User:
Start: 12/31/04 End: - Due: -

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01557114 Org: User:
Start: 03/31/11 End: 03/31/16 Due: 03/31/17

A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06781996 Org: User:
Start: 04/15/25 End: 12/15/26 Due: 12/15/27

Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02515877 Org: User:
Start: 01/31/08 End: 04/30/13 Due: 04/30/14

Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies

Phase: N/A Priority: Normal
NCT ID: NCT02517281 Org: User:
Start: 07/12/11 End: 07/31/20 Due: 07/31/21

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002823 Org: User:
Start: 02/28/95 End: - Due: -

A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03314324 Org: User:
Start: 11/29/17 End: 09/25/24 Due: 09/25/25

Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05705791 Org: User:
Start: 02/07/23 End: 08/31/26 Due: 08/31/27

A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02857569 Org: User:
Start: 12/05/16 End: 05/20/22 Due: 05/20/23